Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update
Avacta Group PLC (AIM:AVCT) Notice of Results
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will announce its unaudited interim results for the six months ended 30 June
Omega Diagnostics Gp (AIM:ODX) Directorate Change
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 20th August 2023
The Golden Goose
Share Talk Weekly Small Cap Movers & Shakers, Saturday 19th August 2023
Fintech firm Glantus Holdings PLC (AIM: GLAN), a UK small-cap, has succumbed to the ongoing trend of take-private offers affecting the junior market.
Abingdon Health PLC (AIM:ABDX) Salistick™ to be launched in Tesco
Salistick™, the first ever saliva pregnancy test, to be launched in Tesco
Avacta Group PLC (AIM:AVCT) Completion of Fifth Dose Escalation in AVA6000
Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
Abingdon Health PLC (AIM:ABDX) Launch of Salistick™ saliva pregnancy test
Superdrug to sell Salistick™, the first ever saliva pregnancy test, initially in 400 stores and online Salistick™ also to launch on the Abingdon Simply Test website
Avacta Group PLC (AIM:AVCT) Statement regarding market speculation
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, notes the recent market speculation regarding possible fundraising.
Avacta Group PLC (AIM:AVCT) AGM and Shareholder Event Detailed Agenda
Avacta Annual General Meeting and Shareholder Event Detailed Agenda
Avacta Group PLC – Second Milestone in AffyXell Joint Venture
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake